ImmunoMetrix™ Antibodies:
The New Standard of Characterization
All Antibodies Meet CPTAC Standards
The bridge from gold-standard characterization to your next breakthrough. Leinco Technologies is proud to announce the exclusive launch of ImmunoMetrix™ , a premier line of monoclonal antibodies originated and rigorously characterized by the NCI’s Clinical Proteomic Tumor Analysis Consortium (CPTAC). By combining the CPTAC’s unrivaled validation standards with Leinco’s 30+ years of manufacturing excellence, we provide researchers with the most reliable affinity reagents available for cancer research today.
Why Choose ImmunoMetrix™?
In an era of reproducibility challenges, ImmunoMetrix™ offers the “Rigor and Reproducibility” that modern science demands. Every clone in the ImmunoMetrix™ portfolio has undergone an exhaustive characterization pipeline at the Antibody Characterization Laboratory (ACL).
- CPTAC-Validated: Each antibody is backed by a comprehensive data package.
- Fit-for-Purpose: Validated across multiple orthologous platforms, including IHC, Western Blot, Flow Cytometry, and SPR.
- Renewable & Recombinant: Ensuring absolute lot-to-lot consistency for long-term longitudinal studies.
- Exclusive Access: These high-performance clones, previously available only through limited channels, are now available exclusively through Leinco’s global distribution network.
Unrivaled Technical Rigor
Every ImmunoMetrix™ antibody is accompanied by a Characterization Report featuring:
| Antibody (Clone) | Specialization | Key Features & Applications |
|---|---|---|
| ANTI-PD-L1 (CPTC-CD274-1) | Mass Spec Standard | The definitive clone for Immuno-MRM. CPTAC-verified for quantifiable, clinical-grade detection in complex tumor lysates. |
| ANTI-CD163 (CPTC-CD163-1) | Spatial Proteomics Ready | Premier M2 macrophage specialist. Optimized for IHC and Imaging Mass Cytometry (IMC) to map the TME with high signal-to-noise. |
| ANTI-GAPDH (CPTC-GAPDH-1) | Loading Control Standard | A recombinant monoclonal designed to replace inconsistent polyclonals. Extensively validated for absolute lot-to-lot consistency in IF and WB. |
| ANTI-CD47 (CPTC-CD47-4) | Innate Checkpoint Precision | Validated by the NCI for therapeutic research via Surface Plasmon Resonance (SPR), ensuring superior binding kinetics for monitoring receptor expression. |
Applications You Can Trust
ImmunoMetrix™ antibodies are ready for immediate integration into your workflow:
- IHC & IF – Validated for both fresh-frozen and FFPE tissue sections.
- Flow Cytometry – Optimized for high signal-to-noise ratios in complex cell populations.
- CellCarta Immuno-MRM – Mass spectrometry-grade reagents for quantitative proteomics.
- Western Blotting – Clear, specific bands with minimal background interference.
Ready to Enhance Your Research?
Stop searching for antibodies that might work. Start using the ones NCI knows will work.
